Article date: January 30, 2009
You may have heard that taking certain vitamin or mineral supplements can lower prostate cancer risk. While some studies have found that there might be a protective benefit from some supplements, recent results from 2 large studies didn't find any.
In 2001, researchers from the National Cancer Institute (NCI) and the Southwest Oncology Group (SWOG) launched the massive SELECT study (short for Selenium and Vitamin E Cancer Prevention Trial) to find out whether taking selenium and vitamin E supplements could protect men from prostate cancer. In October 2008, researchers halted the trial after early analysis showed the supplements weren't working, and in fact, in some cases, may have been doing more harm than good.
More than 35,000 men over age 50 in the US, Puerto Rico, and Canada were enrolled in the trial. Each participant was randomly assigned to take either selenium, vitamin E, a combination of the two, or a placebo for the course of the study. After an average of 5 years, the analysis found no lower risk of prostate cancer in men taking the supplements, either alone or together.
Men who were taking only vitamin E actually had a slightly higher risk of developing prostate cancer. And men taking only selenium seemed to have a slightly higher risk of developing diabetes. This increased risk was not statistically significant in either case. That means the findings could be due to chance; they don't prove the supplements raise prostate cancer and diabetes risk. Still, researchers called the findings "concerning."
The men in the study were told to stop taking their study pills. The researchers plan to continue monitoring the participants for about 3 more years to see if there are long-term effects (good or bad) from taking the supplements.
In another large, long-term trial, called the Physicians' Health Study II, researchers from Brigham and Women's Hospital and Harvard Medical School studied whether taking vitamin E or vitamin C could reduce the risk of prostate cancer. Nearly 15,000 male doctors participated in the trial. After an average of 8 years, neither vitamin E nor vitamin C seemed to lower the risk of prostate cancer. However, taking the supplements also did not appear to cause any harm.
The results of both studies were published in the January 7, 2009 issue of the Journal of the American Medical Association.
So, what can you do to reduce your risk of prostate cancer? While it now seems unlikely that specific supplements will have a major effect on risk, other factors, such as maintaining a healthy weight and eating a healthy diet, may still play a role. Following the American Cancer Society’s guidelines for nutrition and physical activity may lower prostate cancer risk, and can clearly have other health benefits, including reducing the risk of some other cancers.
Tomatoes (raw, cooked, or in tomato products such as sauces or ketchup), pink grapefruit, and watermelon are rich in lycopenes, antioxidants that help prevent damage to DNA. Some studies have suggested lycopenes may help lower prostate cancer risk, although a more recent study found no link between blood levels of lycopene and risk of prostate cancer. Research in this area continues.
For more information, see "What are the risk factors for prostate cancer?" and "Can prostate cancer be prevented?"
"Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers." Published in the January 7, 2009 issue of the Journal of the American Medical Association. Corresponding Author: Scott M. Lippman, MD, Department of Thoracic and Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas.
"Vitamins E and C in the Prevention of Prostate and Total Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial." Published in the January 7, 2009 issue of the Journal of the American Medical Association. Corresponding author: J. Michael Gaziano, MD, MPH, Brigham and Women's Hospital, Boston, Massachusetts.
Reviewed by: Members of the ACS Medical Content Staff
ACS News Center stories are provided as a source of cancer-related news and are not intended to be used as press releases.
Thank you for your feedback.